Found 95 matching trials
Korea Comirnaty Post-marketing Surveillance N/A This study will collect information on the safety of BNT162b2 products for ...
Show More Status
Active Not Recruiting
Learn More & Join Trial
COVID Protection After Transplant-Immunosuppression Reduction PHASE2 This study will enroll individuals who have:
* Completed primary series of...
Show More Location
University of California, San Diego
Learn More & Join Trial
Exploring the Immune Response to SARS-CoV-2 modRNA Vaccines in Patients With Secondary Progressive Multiple Sclerosis (AMA-VACC) PHASE4 The purpose of this study was to understand whether participants could moun...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Evaluation of Safety and Immunogenicity of the Recombinant ZR202-CoV and ZR202a-CoV Vaccines in Adults. PHASE1 For Phase 1 only. Additional information will be provided when Phase 2 is i...
Show More Location
Center for Vaccine Development-Mali
Learn More & Join Trial
COVID-19 Booster Vaccination in Persons With Multiple Sclerosis EARLY_PHASE1 The success of the U.S. vaccination program against SARS-Cov-2 is shown by ...
Show More Learn More & Join Trial
Adaptive Immune Response to COVID-19 Vaccination N/A AICOVI (Adaptive Immune Response to COVID-19 Vaccination) is a prospective ...
Show More Location
University Medicine Greifswald
Learn More & Join Trial
Prospective Monitoring of BNT162b2 Second Vaccination Booster Effects in Health Care Workers (HCW) N/A The SARS-CoV-2 virus causes severe respiratory illness and is an ongoing gl...
Show More Learn More & Join Trial
A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants PHASE3 This is a Phase 3, randomized, observer-blind study in healthy individuals....
Show More Location
Kaiser Permanente Oakland
Learn More & Join Trial
A Phase I/II Study of GLB-COV2-043 as a COVID-19 Vaccine Booster PHASE1 The scope of this Phase I/II study is to determine whether GLB-COV2-043 is ...
Show More Location
Multiple Locations
Learn More & Join Trial
COVID-19 Fourth Dose Study in Australia PHASE3 This clinical trial will be a blinded, randomised study to determine the sa...
Show More Location
Royal Children's Hospital, Murdoch Children's Research Institute
Learn More & Join Trial